Pelthos Therapeutics (PTHS) Earnings Date & Reports

Pelthos Therapeutics Inc is a biopharmaceutical company committed to commercializing safe and efficacious therapeutic products to help patients with unmet treatment burdens... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PTHS is expected to report earnings to fall 90.61% to -28 cents per share on November 12

Pelthos Therapeutics PTHS Stock Earnings Reports

Q3'26

Est.

$-0.29

Q1'26

Missed

by $2.58

Q4'25

Missed

by $6.33

The last earnings report on May 14 showed earnings per share of -308 cents, missing the estimate of -50 cents. With 18.95K shares outstanding, the current market capitalization sits at 83.84M.

View a ticker or compare two or three

PTHS

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for PTHS